Japan Fund Set To Get Around Patent Protections On Several Drugs
This article was originally published in PharmAsia News
Executive Summary
A Japanese fund is set to begin doing business by the end of September in support of research to bypass supposed roadblocks imposed by patents in several areas
You may also be interested in...
Coronavirus Notebook: EMA Data Hack Aimed At 'Undermining Trust' In Vaccines, Russia Plans EU Sputnik V Filing Next Month
France has reported on side-effect reports concerning the Pfizer/BioNTech vaccine, and the World Health Organization has warned that plans to provide global equitable access to coronavirus vaccines are at risk.
Norway COVID-19 Vaccine Deaths Draw Global Attention
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. Australia is looking at whether specific warnings about risks of vaccination in the very frail elderly or terminally ill should be included in the product information.
Viagra Connect To Launch In Ireland Following Rx-to-OTC Switch
Viagra will soon be available OTC in Ireland following a successful switch, but patients will have to complete a mandatory consultation with a pharmacist before the ED treatment can be supplied.
Need a specific report? 1000+ reports available
Buy Reports